Comprehensive Analysis of Clinical, Pathological, and Molecular Features in Chronic Myelomonocytic Leukemia: Frequent ASXL1 and NRAS Mutations and Higher Mutation Burden in Myeloproliferative CMML Compared to Myelodysplastic CMML
Etoposide inferior to hydroxycarbamide for CMML
Topotecan in myelodysplastic syndrome and CMML
6-Merkaptopurin in the treatment of CMML
An adaptive survival prediction model in CMML
Przwlekła białaczka mielomonocytowa (CMML)
Przewlekła białaczka mielomonocytowa (CMML)
COMBINATION THERAPY FOR CMML AND MDS